Skip to main content
OpenTrials
Completed

NCT Number: NCT01564485

Cardiac CT's Role in Asymptomatic Patients With Diabetes and Metabolic Syndrome

This study looked at the role of cardiac CT in improving risk factor control in those with diabetes.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Hyperinsulinism Insulin Resistance Metabolic Diseases Metabolic Syndrome Nutritional and Metabolic Diseases

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of California, Irvine Medical Center

Orange, California, 92868, United States

About this study

This study examined whether doing a cardiac screening test, the cardiac CT, would result in patients paying more attention to controlling their risk factors.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age > 18
  • Diabetes
  • Metabolic Syndrome

Exclusion criteria

  • Symptoms of heart disease
  • Heart Disease
  • Renal disease

Treatment and study plan

cardiac CT

Diagnostic Test

A cardiac CT involves a non-invasive test of the coronary arteries.

Usual medical care

Behavioral

Patients would be treated by their primary care physicians with usual medical care with drugs such as lipid lowering medication, blood pressure lowering medications, and blood glucose lowering medications. The study will not specify which drugs to use and will it up to the individual physician's discretion.

Other names: Usual medical care would include control of blood pressure, blood glucose, and cholesterol by the primary care physician.

Primary outcomes

  1. Systolic BP Pressure

    Time frame: Five year follow up

    After randomization to either obtain cardiac CT or usual care, patients will be followed for 5 years (with assessment of outcomes at every 6 months) to see any difference in control of systolic blood pressure. The outcome with be assessed as a continuous measure.

Other outcomes

  1. Change in Treatment by PCP

    Time frame: 2 years

    Medication dose change or medication start/stop

Sponsors and collaborators

Lead sponsor

University of California, Irvine

Other

Registry information

Official study title

Role of Cardiac CT in Risk Factor Control in Asymptomatic Patients With Diabetes

Acronym: CTRAD

Important dates

Study start
2008
Primary completion
2016
Study completion
2016
First posted
Mar 27, 2012
Registry last updated
Jun 8, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.